Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium Avium
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01355-09
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2010
Authors
Publisher
American Society for Microbiology